ENDOGENOUS neuromodulatory molecules are commonly coupled to specific
metabolic enzymes to ensure rapid signal inactivation, Thus, acetylcho
line is hydrolysed by acetylcholine esterase(1) and tryptamine neurotr
ansmitters like serotonin are degraded by monoamine oxidases(2). Previ
ously, we reported the structure and sleep-inducing properties of cis-
9-octadecenamide, a lipid isolated from the cerebrospinal fluid of sle
ep-deprived cats(3). cis-9-Octadecenamide, or oleamide, has since been
shown to affect serotonergic systems(4) and block gap-junction commun
ication in glial cells (our unpublished results). We also identified a
membrane-bound enzyme activity that hydrolyses oleamide to its inacti
ve acid, oleic acid(3). We now report the mechanism-based isolation, c
loning and expression of this enzyme activity, originally named oleami
de hydrolase(5), from rat liver plasma membranes. We also show that ol
eamide hydrolase converts anandamide, a fatty-acid amide identified as
the endogenous ligand for the cannabinoid receptor(6), to arachidonic
acid, indicating that oleamide hydrolase may serve as the general ina
ctivating enzyme for a growing family of bioactive signalling molecule
s, the fatty-acid amides(6-8). Therefore we will hereafter refer to ol
eamide hydrolase as fatty-acid amide hydrolase, in recognition of the
plurality of fatty-acid amides that the enzyme can accept as substrate
s.